Sleep Disorders in Individuals with Fragile X Syndrome: A Literature Review by Alabd, Andrew
Rowan University 
Rowan Digital Works 
Cooper Medical School of Rowan University 
Capstone Projects Cooper Medical School of Rowan University 
2020 
Sleep Disorders in Individuals with Fragile X Syndrome: A 
Literature Review 
Andrew Alabd 
Follow this and additional works at: https://rdw.rowan.edu/cmsru_capstones 
Let us know how access to this document benefits you - 
share your thoughts on our feedback form. 
Recommended Citation 
Alabd, Andrew, "Sleep Disorders in Individuals with Fragile X Syndrome: A Literature Review" (2020). 
Cooper Medical School of Rowan University Capstone Projects. 41. 
https://rdw.rowan.edu/cmsru_capstones/41 
This Poster is brought to you for free and open access by the Cooper Medical School of Rowan University at Rowan 
Digital Works. It has been accepted for inclusion in Cooper Medical School of Rowan University Capstone Projects 
by an authorized administrator of Rowan Digital Works. For more information, please contact brush@rowan.edu. 
Sleep	Disorders	in	Individuals	with	Fragile	X	Syndrome:	
A	Literature	Review
Andrew	Alabd,	Karim	Sedky MD	MSc
Cooper	Medical	School	of	Rowan	University/	Cooper	University	Hospital,	Camden,	NJ	
.
Sample	image
Fragile	X	Syndrome	(FXS),	was	first	described	in	
1943	as	a	form	of	intellectual	disability	(ID).	A	
meta-analysis	of	fifteen	studies	that	included	
7,475	individuals	showed	that	FXS	is	the	second	
cause	of	ID	after	Down	Syndrome	(DS).	The	
disorder	is	linked	to	an	unstable	expansion	of	
CGG	repeat	(>200)	within	the	fragile	X	mental	
retardation	1	gene (FMR1) causing	a	loss	of	
function	in	the	gene.	
The	clinical	spectrum	of	FXS	is	wide	including	
intellectual	disability	and	other	multi-system	
symptoms.	Therefore,	confirmed	diagnosis	is	
made	based	upon	the	detection	of	alterations	
to FMR1	gene.	While	males	tend	to	present	with	
intellectual	disability,	females	tend	to	present	
with	learning	disability	and	less	sever	intellectual	
limitations.	
Individuals	diagnosed	with	Fragile	X	Syndrome	
(FXS)	are	predisposed	to	sleep	disorders	including	
obstructive	sleep	apnea	(OSA).	The	aim	of	this	
study	is	to	assess	the	prevalence	of	sleep	
disorders	and	comorbid	associated	sleep	
problems	in	this	population	along	with	
appropriate	pharmacological	and/	or	non-
pharmacological	interventions.
.METHODS
RESULTSBACKGROUND CONCLUSION
REFERENCES
A	literature	search	was	conducted	using	the	
following	search	engines:	google	scholar,	PubMed,	
Ovid,	Cochrane	library,	and	PLOS.	All	English	
language	published	articles	were	identified	by	
searching	for	“Fragile	X	Syndrome”	crossed	by	
“obstructive	sleep	apnea”	and	“sleep	problems”.	
Literature	review	was	done	on	selected	studies	to	
assess	a	possible	increased	risk	of	OSA	in	
individuals	with	FXS	or	lack	thereof	and	best	
options	for	management.	Crossing	OSA,	sleep	
problems,	FXS,	and	management	was	used	to	
identify	articles	with	patient	management	options	
in	different	populations	and	their	outcomes.	
The	overall	discrepancy	in	the	prevalence	of	sleep	
disorder	in	children	with	FXS	between	the	studies	
in	the	literature	can	probably	be	attributed	to	
differences	in	study	design,	sample	size,	and	data	
collection	protocols.	However,	it	appears	that	
both	sleep	disorders	as	well	as	OSA	is	more	
common	in	FXS	than	in	the	general	population.
Patients	showed	improvement	in	sleep	in	
response	to	behavioral	interventions,	melatonin,	
GABA	receptor	agonists	and	alpha-2-agonist.	
While	CPAP	is	the	gold	standard	for	OSA	
treatment,	compliance	is	poor	and	challenging	in	
FXS	patients.	CPAP	refractory	patients	can	benefit	
from	several	surgical	interventions.	
More	epidemiological	research	is	needed	on	
individuals	diagnosed	with	FXS,	including	a	focus	
on	identifying	the	possible	role	that	factors	such	
as	gender,	age,	BMI,	and	other	comorbid	medical	
problems	which	may	be	risk	factors	for	OSA.	
Epidemiology	and	causes	of	Sleep	Difficulties	in	FXS
Polysomnography	(PSG)	has	been	used	as	the	reference	standard	for	the	diagnosis	of	OSA,	
especially	in	children.	Other	diagnostic	methods	were	utilized	in	multiple	studies	including:	pulse	
oximetry	or	parental	reports	(e.g.,	studies	using	OSA-18	questionnaire).	However,	these	later	
modalities	while	cheaper	and	easier	to	implement,	is	not	as	accurate	as	the	in-laboratory	PSG.	
Sleep	disorders	as	well	as	OSA	is	more	common	in	FXS	than	in	the	general	population	(35-50%	in	
FXS	vs	1-10%	in	normal	children).	An	analysis	of	90	children	with	FXS	using	parents	reported	
CSHQ	found	that	47%	of	children	with	FXS	had	clinically	significant	sleep	problem.	Parents	of	FXS	
patients	reported	a	number	of		sleep	problems	including:	difficulty	falling	asleep,	frequent	
awakening,	and	restless	sleep.	
A	recent	national	survey	using	body	mass	index	(BMI)	data	from	718	children,	found	that	male	
children	with	FXS	had	a	higher	prevalence	rate	of	obesity	(31%)	when	compared	to	age	matched	
control	children	(18%).	This	higher	prevalence	of	obesity	in	FXS	individuals	might	be	one	of	the	
major	contributors	to	OSA	in	this	population.	Other	causes	includes:	narrow	oropharynx,	
retrognathia,	hypotonia and	connective	tissue	disease.
Comorbid	Self-Injurious	Behavior	in	FXS	Patients	with	Sleep	Difficulties
Self-injurious	behavior	(SIB)	was	reported	in	58%	of	the	participants,	with	age	of	onset	around	3	
years	old.	The	primary	form	of	frequent	(i.e.,	daily)	self-biting	or	chewing	is	directed	toward	the	
hand	or	arm	which	adds	additional	challenge	and	burden	to	the	caregivers	of	patients	with	FXS.
Pharmacological	and	non-pharmacological	Interventions
Behavioral	strategies	including:	circadian	rhythm	management,	positive	bedtime	routines,	white	
noise,	graduated	extinction,	scheduled	awakening	and	parent	training	programs showed	
significant	results	in	alleviating	sleep	problems.	
Many	FXS	children	might	not	show	adequate	response	to	the	above	strategies	and	will	benefit	
from	a	pharmacological	intervention	as	melatonin,	GABA	receptor	agonists	and	alpha-2- agonist.	
In	a	study	involving	127	FXS	carrier	gene	compared	to	86	controls,	RLS	symptoms	were	increased	
by	1.9	fold.	Since	FMRP	and	FMR1	has	been	involved	in	dopamine	activity,	it	is	thus	expected	that	
dopaminergic	agents	might	help	sleep	in	this	population.
CPAP	is	considered	the	gold	standard	treatment	for	OSA	and was	shown effective	in	reducing	
symptoms	of	sleepiness	and	improving	the	quality	of	life	measures	in	patients	with	moderate	and	
severe	OSA, the	compliance	to	CPAP	has	long	been	reported	to	be	poor.	Therefore,	surgical	
interventions	can	be	helpful	in	alleviating	the	OSA	symptoms	in	non-compliant	and	CPAP	
refractory patients.	Surgical	interventions	includes:	rapid	maxillary	expansion	(RME),	mandibular	
distraction	osteogenesis	(MDO),	and	mini	tracheotomies
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